Indeed, the addition of BH3 mimetics such as ABT-737 (which inhibits pro-survival BCL2 proteins) rescued the ability of H-1PV to induce apoptosis in these cells, thereby strongly potentiating H-1PV glioma cell oncolysis [61]. Here, BCL2 is linked to central nervous system cancer.